Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1998052599) ATRIAL NATRIURETIC PEPTIDE (ANP) AS AN ADDITIVE TO PERITONEAL DIALYSIS SOLUTIONS
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1998/052599 International Application No.: PCT/US1998/010511
Publication Date: 26.11.1998 International Filing Date: 21.05.1998
IPC:
A61K 38/22 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17
from animals; from humans
22
Hormones
Applicants:
BAXTER INTERNATIONAL INC. [US/US]; One Baxter Parkway Deerfield, IL 60015, US
Inventors:
CHEN, Chi, J.; US
SHOCKLEY, Ty, R.; US
JOHNSTON, Miles, G.; CA
Agent:
BORECKI, Thomas, S. ; Baxter Healthcare Corporation One Baxter Parkway DF3-3E Deerfield, IL 60015, US
Priority Data:
08/862,48023.05.1997US
Title (EN) ATRIAL NATRIURETIC PEPTIDE (ANP) AS AN ADDITIVE TO PERITONEAL DIALYSIS SOLUTIONS
(FR) PEPTIDE NATRIURETIQUE ATRIAL (ANP) UTILISE COMME ADDITIF DE SOLUTIONS DE DIALYSE PERITONEALE
Abstract:
(EN) The present invention provides a peritoneal dialysis solution that contains atrial natriuretic peptide (ANP), a derivative of ANP, an analogue of ANP, a substance that binds ANP to clearance receptors or a substance that promotes ANP synthesis, which results in an increased net ultrafiltration and increased sodium clearance experienced in peritoneal dialysis patients.
(FR) La présente invention concerne une solution de dialyse péritonéale renfermant un peptide natriurétique atrial (ANP), un dérivé d'ANP, un analogue d'ANP, une substance liant l'ANP à des récepteurs de clairance ou une substance favorisant la synthèse d'ANP, ce qui a permis d'observer chez des patients soumis à une dialyse péritonéale une ultrafiltration nette et une clairance du sodium accrues.
Designated States: AU, BR, CA, CN, ID, JP, KR, MX, SG
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
MXPA/a/1999/000703KR1020000029447SG61148ES2186166EP0914147JP2000516836
CN1226832CA2261681AU1998076926